There are four common ways to be prescribed and followed on a GLP-1. They differ less in the medicine and more in who examines you, how often, and how the bill is built. This page lays them side by side. The pages after it take each one in turn.
The four models in one table
In-person obesity medicine
Clinic focused on weight care
- Exam
- Hands-on, vitals and often body composition on site
- Prescriber
- Physician, often ABOM-certified, or NP/PA in the practice
- Follow-up
- Room visits at titration steps, then every 1 to 3 months
- Billing
- Usually insurance for visits; some cash programs
- Wait
- Often weeks
Best when you want the widest scope in one place and can travel.
Primary care
Your existing clinician
- Exam
- Hands-on; already has your history
- Prescriber
- MD, DO, NP or PA in family or internal medicine
- Follow-up
- Folded into routine visits; varies widely
- Billing
- Insurance, standard visit copay
- Wait
- Days to weeks
Best when your clinician is willing and you value continuity.
Telehealth-only
Remote medical group
- Exam
- None in person; relies on what you report and upload
- Prescriber
- Licensed in your state, employed by the program's medical group
- Follow-up
- Messaging, sometimes video; structure varies
- Billing
- Mostly cash membership, medication often bundled
- Wait
- Hours to days
Best when speed and no travel matter most and you have no condition that needs close monitoring.
Hybrid
Room for the big visits, remote for the rest
- Exam
- At intake and periodic checks
- Prescriber
- Same clinician across both settings
- Follow-up
- Video or messaging between in-person visits
- Billing
- Mixed; ask what each visit type costs
- Wait
- Weeks for the first visit, then fast
Best when you want an exam without every visit being a trip.
What every model must do
Three things do not change with the medium. The FSMB 2022 telemedicine report says the standard of care for telemedicine should be equivalent to in-person care, that the prescriber must be licensed where the patient is located, and that a questionnaire alone is not enough to establish care. The AMA's opinion 1.2.12 adds informed consent about the limits of the technology and a duty to promote continuity of care, including sending information to your other clinicians.
So whichever model you pick, expect a history, screening for the label contraindications (see what a good intake includes), a plan for labs, and a named way to reach someone when a side effect appears. If a clinic of any model skips those, the model is not the problem.
What society guidance says about the care itself
The AACE/ACE 2016 guideline frames obesity as a chronic disease needing a medical evaluation, lifestyle therapy, and where indicated medication, with follow-up on response and adverse effects. The OMA's 2022 clinical practice statement treats anti-obesity medication as one of four pillars alongside nutrition, physical activity and behaviour, which is an argument for a model that can at least point you to the other three. The AGA 2022 guideline recommends adding pharmacotherapy to lifestyle intervention for adults with obesity or overweight with weight-related complications who have not responded to lifestyle intervention alone. None of these documents says the care must happen in a room. All of them assume it happens under a clinician who knows your history and follows you.
How to use the rest of this site
- Read the page for the one or two models you are leaning toward.
- Take the clinic fit quiz. It ranks the four models against your priorities and names no provider.
- Take the first-call questions to any clinic you are considering.
- For scored evaluations of named programs, use formblendsreviews.com, which applies a published rubric. This site does not evaluate providers.
Questions people ask
Is telehealth GLP-1 care lower quality than in-person care?
Not by definition. The FSMB says the standard of care is the same regardless of the medium. Quality depends on whether the intake covers your history, labs and contraindications, whether visits are live when they need to be, and whether follow-up is structured. A poor in-person clinic and a poor telehealth program fail in the same ways.
Can I combine models?
Yes, and many people end up doing so without naming it: a primary care clinician for labs and blood pressure, a remote program for the prescription and refills. The risk is that nobody holds the whole picture. Decide who that person is and make sure records flow to them.
Sources
- FSMB. The Appropriate Use of Telemedicine Technologies in the Practice of Medicine: Report of the FSMB Workgroup on Telemedicine, April 2022 Accessed September 4, 2026.
- AMA Code of Medical Ethics, Opinion 1.2.12: Ethical Practice in Telemedicine Accessed September 4, 2026.
- Garvey WT et al. AACE/ACE Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocr Pract 2016. PubMed 27219496 Accessed September 4, 2026.
- Bays HE et al. Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association Clinical Practice Statement 2022. Obesity Pillars 2022. PubMed 37990711 Accessed September 4, 2026.
- Grunvald E et al. AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity. Gastroenterology 2022. PubMed 36273831 Accessed September 4, 2026.
Canonical URL: https://formblendsclinics.com/care-models/care-models-compared. Written by the FormBlends editorial team. This page is educational and is not medical advice; see the medical disclaimer.